SEMAX SPRAY

SEMAX SPRAY

    $69.99

    A 7-amino acid synthetic heptapeptide analog of ACTH (4-10) that upregulates BDNF expression and modulates the TrkB signaling pathway, studied for cognitive enhancement and neuroprotection in clinical research. Premium Research Peptide.

    1000 in stock

    🔥 Exclusive Crypto Offer

    Get an INSTANT 15% DISCOUNT when you pay with Bitcoin, Ethereum, Dogecoin, Bitcoin Cash, XRP, Solana, or USDT.

    âš¡ Don't have crypto? Buy it here in 5 minutes with easy guidance.

    💡 Pro Tip: You can also pay with cryptocurrency using your verified Cash App or PayPal account for a fast and secure checkout!

    SKU: am-1785210815230-3 Category:

      Certificate of Analysis

      Third Party Tested • ISO/IEC 17025 Accredited • Premium Quality

      Purity: 99.53% (✓ Passed Full QC Panel)

      Semax 10mg Specification

      Variant Semax 10mg
      Lot # SMX0001
      Labeled 10mg
      Actual 10.53mg
      Tested May 29, 2026
      Full QC Panel 7× tested
      Purity (HPLC) 99.53%
      Net Peptide Content 10.53mg
      Identity (HPLC) Semax
      HPLC Conformity mean 99.40%
      Heavy Metals (ICP-MS) Not Detected
      Sterility (PCR) No Growth
      Endotoxin (USP <85>) < 0.05 EU/mLISO/IEC 17025 Accredited

      Frequently Researched Together

      Neuropeptide research compounds

      Molecular Profile

      What Is Semax?

      Synthetic heptapeptide analog of ACTH (4-10) with C-terminal Pro-Gly-Pro extension for enhanced stability

      HeptapeptideACTH Analog

      Type Synthetic heptapeptide
      CAS Number 80714-61-0
      Molecular Formula C37H51N9O10S
      Molecular Weight 813.9 g/mol
      Amino Acids 7 residues
      Sequence Met-Glu-His-Phe-Pro-Gly-Pro
      PubChem Database

      Physical Properties

      Handling & Storage

      Supplied ready to use. No reconstitution required.

      Ready to use
      Protect from direct light
      Appearance Clear, colorless solution
      Diluent Antimicrobial preserved water
      Storage 34°F to 120°F (1°C to 49°C)
      Shelf life Up to 8 months

      Development Status

      Regulatory Information

      Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences

      Developer Russian Academy of SciencesApprovalRussia (1990s)
      Indication sStroke, cognitive impairmentFormulations0.1% and 1% nasal sprayUS StatusNot FDA-approvedRelated PeptideSelank (tuftsin analog)Wikipedia